SpyGlass Pharma Raises $75M Series D Round
SpyGlass Pharma Inc. has raised a $75 million Series D round that brings the company closer to commercializing its intraocular lens (IOL). Proceeds from the round, announced at the beginning of June, will help fund two large Phase 3 trials, which are set to begin later this year. “This not Read More










